MOASC members are here at the #ASCOAdvocacySummit to advocate for Action to mitigate drug shortages, continuation of telegraph flexibilities and robust cancer research funding
Oncology Conference Videos
Oncology News
In the realm of advancements in CAR T-cell therapy for relapsed/refractory mantle cell lymphoma (MCL),…
In this ASH 2023 interview, Dr. Jos Melenhorst discusses a collaborative study on single-cell multi-omics…
Al-Ola Abdallah, MD, Associate Professor of Medicine at The University of Kansas, conducted a study…
Jeff Sharman, MD, a medical oncologist at the Willamette Ballet Cancer Institute and Research Center,…
John F. Seymour, MBBS, Ph.D., FRACP, a clinical haematologist and the Director of the Haematology…
Allen Wilbanks stands at the forefront of SABCS 2023, the setting for a conversation with…
Rabi Hanna, MD, from the Department of Pediatric Hematology Oncology and BMT at Cleveland Clinic…
At ASH 2023, Ola Landgren, MD, Professor of Medicine and Chief Division of Myeloma at…
By. Ash Alizadeh, MD Date: 12/13/2023 At ASH 2023, Dr. Ash Alizadeh, a distinguished medical…
David J. Andorsky, MD, an Associate Chair for US Oncology Hematology Research and a member…
Teclistamab FDA approval biweekly dosing in Relapsed or Refractory Multiple Myeloma (3 KOL Video Interviews…
… The Medical Oncology Association of Southern California (MOASC) 2024 Summit has once again set…